A convertible bond of Guardant Health Inc, a US precision-oncology company that develops blood-based (liquid-biopsy) tests for cancer detection, treatment selection and monitoring.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 49 | Added +606% | 28,291 | $2,889,643 | 0.0% |
| Howard Marks / Oaktree | 69 | Trimmed -88% | 555,000 | $599,677 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.